Novonax vaccine clinical trial results

Last night Novavax published the results of their latest vaccine trial – showing this vaccine to be around 90 per cent effective in preventing coronavirus, and being effective against new UK variant.

  • The results of this vaccine trial look extremely promising. If approved by the medicines regulator, the Novavax vaccine will be a significant boost to our vaccination programme and another weapon in our arsenal to beat the virus. 
  • In August the UK government moved quickly to procure 60 million doses from Novavax. The majority of this vaccine will be manufactured on Teesside and delivered during this year, if approved for use. We owe our thanks to the brilliant UK scientists, researchers and volunteers who took part in clinical trials. 
  • This news puts the UK at the forefront of yet another medical breakthrough against Covid. The NHS stands ready to roll this vaccine out as quickly as possible to those most at risk if it is authorised – helping us defeat this virus.


Popular posts from this blog

Nick Herbert on his visit to flood hit areas of Cumbria

Quotes of the day 19th August 2020

Quote of the day 24th July 2020